Article
A rasopathy phenotype with severe congenital hypertrophic obstructive cardiomyopathy associated with a PTPN11 mutation and a novel variant in SOS1.
American journal of medical genetics. Part A - 1 Jun 2012
Fahrner Jill A, Frazier Aisha, Bachir Suha, Walsh Michael F, Applegate Carolyn D, Thompson Reid, Halushka Marc K, Murphy Anne M, Gunay-Aygun Meral
Abstract excerpt
The RAS-MAPK pathway is critical for human growth and development. Abnormalities at different steps of this signaling cascade result in neuro-cardio-facial-cutaneous syndromes, or the RASopathies, a group of disorders with overlapping yet distinct phenotypes. RASopathy patients have variable degrees of intellectual disability, poor growth, relative macrocephaly, ectodermal abnormalities, dysmorphic features, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.